162 related articles for article (PubMed ID: 26757149)
1. Micropellet-loaded rods with dose-independent sustained release properties for individual dosing via the Solid Dosage Pen.
Laukamp EJ; Knop K; Thommes M; Breitkreutz J
Int J Pharm; 2016 Feb; 499(1-2):271-279. PubMed ID: 26757149
[TBL] [Abstract][Full Text] [Related]
2. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
Laukamp EJ; Vynckier AK; Voorspoels J; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2015 Jan; 89():357-64. PubMed ID: 25555454
[TBL] [Abstract][Full Text] [Related]
3. Hot-melt extruded drug-loaded rods: evaluation of the mechanical properties for individual dosing via the Solid Dosage Pen.
Laukamp EJ; Thommes M; Breitkreutz J
Int J Pharm; 2014 Nov; 475(1-2):344-50. PubMed ID: 25195728
[TBL] [Abstract][Full Text] [Related]
4. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: In vitro and in vivo evaluation.
Verstraete G; De Jaeghere W; Vercruysse J; Grymonpré W; Vanhoorne V; Stauffer F; De Beer T; Bezuijen A; Remon JP; Vervaet C
Int J Pharm; 2017 Jan; 517(1-2):88-95. PubMed ID: 27919698
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA - loaded pellets developed for angina chronotherapy: Deconvolution-based formulation design and optimization, pharmacokinetic and pharmacodynamic evaluation.
Yan HX; Li J; Li ZH; Zhang WL; Liu JP
Eur J Pharm Sci; 2015 Aug; 76():156-64. PubMed ID: 25976225
[TBL] [Abstract][Full Text] [Related]
6. Application of active layering and coating techniques in the development of a multiparticulate, controlled release dosage form of a high-dose, highly soluble drug.
Ahmad H; Khalifeh I; Alkhalidi B; Aiedeh K; Alkhatib HS
Pharm Dev Technol; 2014 Aug; 19(5):556-64. PubMed ID: 23767814
[TBL] [Abstract][Full Text] [Related]
7. Development and in vitro evaluation of multiparticulate sustained release carbamazepine formulation.
Tomuţă I; Leucuţa SE
Acta Pol Pharm; 2012; 69(5):951-64. PubMed ID: 23061293
[TBL] [Abstract][Full Text] [Related]
8. Modulating pH-independent release from coated pellets: effect of coating composition on solubilization processes and drug release.
Ensslin S; Moll KP; Metz H; Otz M; Mäder K
Eur J Pharm Biopharm; 2009 May; 72(1):111-8. PubMed ID: 19084061
[TBL] [Abstract][Full Text] [Related]
9. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
Shamma R; Elkasabgy N
Drug Deliv; 2016; 23(2):489-99. PubMed ID: 24892631
[TBL] [Abstract][Full Text] [Related]
10. New insight into modified release pellets - Internal structure and drug release mechanism.
Ensslin S; Moll KP; Paulus K; Mäder K
J Control Release; 2008 Jun; 128(2):149-56. PubMed ID: 18433911
[TBL] [Abstract][Full Text] [Related]
11. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
[TBL] [Abstract][Full Text] [Related]
12. Improved long term stability of aqueous ethylcellulose film coatings: importance of the type of drug and starter core.
Muschert S; Siepmann F; Cuppok Y; Leclercq B; Carlin B; Siepmann J
Int J Pharm; 2009 Feb; 368(1-2):138-45. PubMed ID: 18996457
[TBL] [Abstract][Full Text] [Related]
13. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
[TBL] [Abstract][Full Text] [Related]
14. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form.
Puri V; Dantuluri AK; Bansal AK
J Pharm Sci; 2012 Jan; 101(1):342-53. PubMed ID: 21935949
[TBL] [Abstract][Full Text] [Related]
15. Development of controlled release amorphous solid dispersions (CRASD) using polyvinyl acetate-based release retarding materials: Effect of dosage form design.
Lugtu-Pe JA; Ghaffari A; Chen K; Kane A; Wu XY
Eur J Pharm Sci; 2018 Nov; 124():319-327. PubMed ID: 30194980
[TBL] [Abstract][Full Text] [Related]
16. Three-Dimensional Printing of Carbamazepine Sustained-Release Scaffold.
Lim SH; Chia SM; Kang L; Yap KY
J Pharm Sci; 2016 Jul; 105(7):2155-63. PubMed ID: 27290630
[TBL] [Abstract][Full Text] [Related]
17. Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.
Djuris J; Ioannis N; Ibric S; Djuric Z; Kachrimanis K
J Pharm Pharmacol; 2014 Feb; 66(2):232-43. PubMed ID: 24350884
[TBL] [Abstract][Full Text] [Related]
18. Development of Polyethylene Glycol and Hard Fat-Based Mucoadhesive Tablets Containing Various Types of Polyvinyl Alcohols as Mucoadhesive Polymers for Buccal Application.
Ikeuchi-Takahashi Y; Kobayashi A; Onishi H
Biol Pharm Bull; 2017 Jun; 40(6):867-877. PubMed ID: 28381813
[TBL] [Abstract][Full Text] [Related]
19. Effect of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer on bioadhesion and release rate property of eplerenone pellets.
Kendre PN; Chaudhari PD
Drug Dev Ind Pharm; 2017 May; 43(5):751-761. PubMed ID: 27494543
[TBL] [Abstract][Full Text] [Related]
20. Release behavior of tanshinone IIA sustained-release pellets based on crack formation theory.
Liu P; Li J; Liu J; Yang J; Fan Y
J Pharm Sci; 2012 Aug; 101(8):2811-20. PubMed ID: 22610467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
